Callan JMB Inc. (CJMB) stock
Close on Nov 12, 2026Market cap $2.17MP/E –Yield –
Callan JMB Inc. saw revenue fall 13.8% to $5.09M over the twelve months to Jun 30, 2026. Free cash flow was -$4.74M. At the latest close the market valued the company at $2.17M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.17M
- P/E ratio
- –
- Price to sales
- 0.43
- Price to book
- 3.18
- Dividend yield
- –
- Free cash flow yield
- -218.35%
Fundamentals
- Revenue
- $5.09M
- Net income
- -$9.77M
- EPS, diluted
- -$1.70
- Free cash flow
- -$4.74M
- Book value per share
- $0.12
- Diluted shares
- 6M
Trading
- Previous close
- $0.31
- Open
- $0.30
- Day's range
- $0.29 – $0.40
- Volume
- 58,014,730
- Average volume (20 days)
- 14,491,213
- 52-week range
- $0.26 – $5.61
- RSI (14 days)
- 26.3
- Volatility (1 year)
- 317.8%
- Relative volume
- 14.12×
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CJMB | S&P 500 | Difference | CJMB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -83.2% | -2.7% | −80.5 pts | ||
| 3 months | -82.8% | -1.7% | −81.0 pts | ||
| Year to date | -66.0% | +11.9% | −77.9 pts | ||
| 1 year | -90.1% | +12.0% | −102.0 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Callan JMB filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- News
About Callan JMB
Services-Business Services, NEC
Callan JMB Inc. provides temperature-controlled logistics, fulfillment, and monitoring services primarily for the life sciences sector. The company specializes in cold chain solutions for temperature-sensitive items such as biological materials, vaccines, and cell therapies. Its primary offerings include emergency preparedness and rapid response deployment, specialized reusable thermal packaging, fulfillment services, and proprietary predictive tracking technologies, including Sentry monitoring and Ship2Q inventory software. Callan JMB serves life sciences organizations, commercial healthcare clients, and public sector entities, including government agencies, the United Nations, and NATO.
Company profile, executives and historyCallan JMB stock: common questions
What is Callan JMB's stock price?
CJMB closed at $0.38 on Nov 12, 2026, up 22.00% on the day. Over the past 52 weeks it traded between $0.26 and $5.61.
What is Callan JMB's market cap?
Callan JMB was worth $2.17M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CJMB's P/E ratio?
Callan JMB lost money over the twelve months to Jun 30, 2026 (diluted EPS -$1.70), so it has no meaningful P/E ratio.
How much revenue does Callan JMB make?
Callan JMB reported revenue of $5.09M for the twelve months to Jun 30, 2026, down 13.8% from a year earlier.
Does Callan JMB pay a dividend?
No. Callan JMB has not paid a cash dividend over the last twelve months.
How has CJMB stock performed over the past year?
Including dividends, CJMB returned -90.1% over the past year, against +12.0% for the S&P 500.
How many CJMB shares are sold short?
0M shares were sold short at the latest FINRA report, 11.24% of the float, or 1.0 days of average trading volume.
Who are Callan JMB's competitors?
Companies most similar to Callan JMB by business, industry and size include OLB, FRQN, PAYD, AHG, ASFH.
See a number that looks wrong?